Jordi Naval – CEO, Biocat, Spain

Jordi Naval, CEO of Biocat, describes the evolution of the BioRegion of Catalonia as an increasingly relevant biotechnology hub in Spain and Europe. Naval also elaborates on the role of Biocat in tackling the challenge of translating basic research into functional innovation which can impact the healthcare ecosystem.  
Now, we are on the next step of entrepreneurial development based on strong scientific groundwork. In this regard, Catalonia is comparable to countries like Denmark, Belgium, Austria, and Ireland in terms of GDP and population
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report